MUC1 induces drug resistance in pancreatic cancer cells via upregulation of multidrug resistance genes

MUC1 Enhances Tumor Progression and Contributes Toward Immunosuppression in a Mouse Model of Spontaneous Pancreatic Adenocarcinoma

(2014) T. L. Tinder et al.   JOURNAL OF IMMUNOLOGY

MUC1 regulates PDGFA expression during pancreatic cancer progression

(2012) M Sahraei et al.   ONCOGENE

Pancreatic Ductal Adenocarcinoma Mice Lacking Mucin 1 Have a Profound Defect in Tumor Growth and Metastasis

(2011) D. M. Besmer et al.   CANCER RESEARCH

Classical resistance mechanisms

(2011) W. Jäger   INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS

Pancreatic cancer: understanding and overcoming chemoresistance

(2010) Zhiwei Wang et al.   Nature Reviews Gastroenterology & Hepatology

The reactive tumor microenvironment: MUC1 signaling directly reprograms transcription of CTGF

(2010) M E Behrens et al.   ONCOGENE

MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition

(2010) L D Roy et al.   ONCOGENE

Pancreatic cancer: from molecular pathogenesis to targeted therapy

(2008) Alexios Strimpakos et al.   CANCER AND METASTASIS REVIEWS

The Cytoplasmic Tail of MUC1: A Very Busy Place

(2008) D. D. Carson   Science Signaling

ABC multidrug transporters: structure, function and role in chemoresistance

(2007) Frances J Sharom   PHARMACOGENOMICS